{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:48:53Z","timestamp":1786978133710,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1002\/jps.23775","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T16:54:28Z","timestamp":1386176068000},"page":"465-477","source":"Crossref","is-referenced-by-count":40,"title":["Development and Comparison of New High-Efficiency Dry Powder Inhalers for Carrier-Free Formulations"],"prefix":"10.1016","volume":"103","author":[{"given":"Srinivas R.B.","family":"Behara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Worth Longest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale R.","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23775_bb0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1513\/pats.200403-023MS","article-title":"Drug delivery devices: Issues in drug development","volume":"1","author":"Byron","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"10.1002\/jps.23775_bb0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/jamp.2010.0853","article-title":"Inhaler devices: What remains to be done?","volume":"23","author":"Smith","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1002\/jps.23775_bb0003","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.medengphy.2011.12.025","article-title":"Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery\u2014A review for multidisciplinary researchers","volume":"34","author":"Islam","year":"2012","journal-title":"Med End Phys"},{"key":"10.1002\/jps.23775_bb0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/rmed.2001.1276","article-title":"Evolution of dry powder inhaler design, formulation, and performance","volume":"96","author":"Newman","year":"2002","journal-title":"Respir Med"},{"issue":"1","key":"10.1002\/jps.23775_bb0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/jamp.2011.0905","article-title":"In vitro tests for aerosol deposition. I. Scaling a physical model of the upper airways to predict drug deposition variation in normal humans","volume":"25","author":"Delvadia","year":"2012","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.23775_bb0006","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1007\/s11095-012-0691-y","article-title":"Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways","volume":"29","author":"Longest","year":"2012","journal-title":"Pharm Res"},{"issue":"3","key":"10.1002\/jps.23775_bb0007","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/jam.2007.0584","article-title":"In vivo\u2013in vitro comparison of deposition in three mouth\u2013throat models with Qvar and Turbuhaler inhalers","volume":"20","author":"Zhang","year":"2007","journal-title":"J Aerosol Med"},{"issue":"3","key":"10.1002\/jps.23775_bb0008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/jamp.2012.0975","article-title":"In vitro tests for aerosol deposition. II: IVIVCs for different dry powder inhalers in normal adults","volume":"26","author":"Delvadia","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1002\/jps.23775_bb0009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/jam.2006.19.473","article-title":"Degree of throat deposition can explain the variability in lung deposition of inhaled drugs","volume":"19","author":"Borgstrom","year":"2006","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.23775_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1378\/chest.127.1.335","article-title":"Device selection and outcomes of aerosol therapy: ACCP\/ACAAI evidence based guidelines","volume":"127","author":"Dolovich","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1002\/jps.23775_bb0011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/jam.2006.19.36","article-title":"Advances in aerosols: Adult respiratory disease","volume":"19","author":"Smaldone","year":"2006","journal-title":"J Aerosol Med"},{"issue":"6","key":"10.1002\/jps.23775_bb0012","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1164\/ajrccm.153.6.8665030","article-title":"Issues in the use of inhaled glucocorticoids","volume":"153","author":"Kamada","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1002\/jps.23775_bb0013","first-page":"1","article-title":"Aerosolized chemotherapy","volume":"21","author":"Gagnadoux","year":"2008","journal-title":"J Aerosol Med"},{"issue":"4","key":"10.1002\/jps.23775_bb0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jamp.2009.0787","article-title":"Inhalation adjuvant therapy for lung cancer","volume":"23","author":"Yi","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"9","key":"10.1002\/jps.23775_bb0015","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4187\/respcare.01246","article-title":"Pediatric aerosol therapy: New devices and new drugs","volume":"56","author":"Rubin","year":"2011","journal-title":"Respir Care"},{"issue":"3","key":"10.1002\/jps.23775_bb0016","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2012.02.019","article-title":"Insight into pressure drop dependent efficiencies of dry powder inhalers","volume":"46","author":"Behara","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.23775_bb0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/jam.1999.12.75","article-title":"A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: Pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler","volume":"12","author":"Prime","year":"1999","journal-title":"J Aerosol Med"},{"issue":"1","key":"10.1002\/jps.23775_bb0018","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1399-3003.2000.16a29.x","article-title":"Scintigraphic comparison of budesonide deposition from two dry powder inhalers","volume":"16","author":"Newman","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1002\/jps.23775_bb0019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(96)04526-7","article-title":"Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers Part 2: Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers","volume":"138","author":"de Boer","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23775_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaerosci.2003.09.002","article-title":"Predicting extrathoracic deposition from dry powder inhalers","volume":"35","author":"DeHaan","year":"2004","journal-title":"J Aerosol Sci"},{"issue":"12","key":"10.1002\/jps.23775_bb0021","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1007\/s10439-012-0616-2","article-title":"Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways","volume":"40","author":"Longest","year":"2012","journal-title":"Ann Biomed Eng"},{"key":"10.1002\/jps.23775_bb0022","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11095-011-0596-1","article-title":"Condensational growth of combination drug-excipient submicrometer particles: Comparison of CFD predictions with experimental results","volume":"29","author":"Longest","year":"2012","journal-title":"Pharm Res"},{"issue":"9","key":"10.1002\/jps.23775_bb0023","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.2042-7158.2012.01476.x","article-title":"Condensational growth of combination drug\u2013excipient submicrometer particles for targeted high efficiency pulmonary delivery: Evaluation of formulation and delivery device","volume":"64","author":"Hindle","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.23775_bb0024","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/02786826.2011.566592","article-title":"Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols","volume":"45","author":"Longest","year":"2011","journal-title":"Aerosol Sci Technol"},{"issue":"5","key":"10.1002\/jps.23775_bb0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/jamp.2012.0997","article-title":"Targeting aerosol deposition to and within the lung airways using excipient enhanced growth","volume":"26","author":"Tian","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1002\/jps.23775_bb0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2013.01.003","article-title":"Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: Effect of spray drying process conditions on aerosol performance","volume":"443","author":"Son","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23775_bb0027","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejps.2013.04.011","article-title":"Evaluation and modification of commercial dry powder inhalers for the aerosolization of submicrometer excipient enhanced growth (EEG) formulation","volume":"49","author":"Y-J","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23775_bb0028","article-title":"Development of a high efficiency dry powder inhaler: Effects of a new capsule orientation and surface coatings","author":"Behara","year":"2013","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23775_bb0029","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s11095-013-1001-z","article-title":"Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols","volume":"30","author":"Longest","year":"2013","journal-title":"Pharm Res"},{"issue":"2","key":"10.1002\/jps.23775_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(94)00287-F","article-title":"Dose emissions from marketed dry powder inhalers","volume":"116","author":"Hindle","year":"1995","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23775_bb0031","first-page":"3298","article-title":"USP. Physical tests and determinations: Aerosols, nasal sprays, metered-dose inhalers, and dry powder inhalers. United States Pharmacopeia First Supplement, 28-NF, General Chapter (601)","year":"2005","journal-title":"Rockville, Maryland United States Pharmacopeial Convention"},{"key":"10.1002\/jps.23775_bb0032","series-title":"In Contact angle, wettability, and adhesion","article-title":"Relation of the equilibrium contact angle to liquid and solid constitution","author":"Zisman","year":"1964"},{"issue":"3","key":"10.1002\/jps.23775_bb0033","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/jamp.2008.0739","article-title":"Quantitative analysis and design of a spray aerosol inhaler. Part 1: Effects of dilution air inlets and flow paths","volume":"22","author":"Longest","year":"2009","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"9","key":"10.1002\/jps.23775_bb0034","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s11095-005-6155-x","article-title":"Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses","volume":"22","author":"Coates","year":"2005","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/jps.23775_bb0035","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/jps.20603","article-title":"Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size","volume":"95","author":"Coates","year":"2006","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1002\/jps.23775_bb0036","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/jps.20201","article-title":"Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length","volume":"93","author":"Coates","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23775_bb0037","article-title":"Turbulence modeling for CFD","author":"Wilcox","year":"1998"},{"issue":"2","key":"10.1002\/jps.23775_bb0038","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/jamp.2008.0708","article-title":"Evaluation of the respimat soft mist inhaler using a concurrent CFD and in vitro approach","volume":"22","author":"Longest","year":"2009","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1002\/jps.23775_bb0039","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaerosci.2008.03.008","article-title":"Comparison of ambient and spray aerosol deposition in a standard induction port and more realistic mouth-throat geometry","volume":"39","author":"Longest","year":"2008","journal-title":"J Aerosol Sci"},{"key":"10.1002\/jps.23775_bb0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaerosci.2011.07.005","article-title":"Development of a stochastic individual path (SIP) model for predicting the tracheobronchial deposition of pharmaceutical aerosols: Effects of transient inhalation and sampling the airways","volume":"42","author":"Tian","year":"2011","journal-title":"J Aerosol Sci"},{"issue":"21","key":"10.1002\/jps.23775_bb0041","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1016\/j.ces.2011.07.029","article-title":"Kinetics of emitted mass-A study with three dry powder inhaler devices","volume":"66","author":"Behara","year":"2011","journal-title":"Chem Eng Sci"},{"issue":"1,2","key":"10.1002\/jps.23775_bb0042","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2006.02.040","article-title":"Emitted dose estimates from Seretide (R) Diskus (R) and Symbicort (R) Turbuhaler (R) following inhalation by severe asthmatics","volume":"316","author":"Tarsin","year":"2006","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1002\/jps.23775_bb0043","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1211\/jpp.61.12.0002","article-title":"Electrostatics of pharmaceutical inhalation aerosols","volume":"61","author":"Kwok","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1002\/jps.23775_bb0044","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1012181818244","article-title":"Aerosol electrostatics I: Properties of fine powders before and after aerosolization by dry powder inhalers","volume":"14","author":"Byron","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23775_bb0045","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ces.2005.05.002","article-title":"Twenty-first century research needs in electrostatic processes applied to industry and medicine","volume":"61","author":"Mazumder","year":"2006","journal-title":"Chem Eng Sci"},{"issue":"6","key":"10.1002\/jps.23775_bb0046","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11095-005-4587-y","article-title":"The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses","volume":"22","author":"Coates","year":"2005","journal-title":"Pharm Res"},{"issue":"4","key":"10.1002\/jps.23775_bb0047","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1208\/s12248-012-9379-9","article-title":"Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers","volume":"14","author":"Shur","year":"2012","journal-title":"AAPS J"},{"key":"10.1002\/jps.23775_bb0048","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0378-5173(02)00319-8","article-title":"Deagglomeration of dry powder pharmaceutical aerosols","volume":"248","author":"Voss","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23775_bb0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.08.045","article-title":"Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations","volume":"402","author":"Donovan","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23775_bb0050","first-page":"58","article-title":"Factors influencing the dispersion of dry powders as aerosols","volume":"8","author":"Hickey","year":"1994","journal-title":"Pharm Tech"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915306948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915306948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T08:24:42Z","timestamp":1564907082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915306948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0022354915306948"],"URL":"https:\/\/doi.org\/10.1002\/jps.23775","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}